| Product Code: ETC7485347 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong continued to source pancrelipase primarily from Ireland, Belgium, China, Germany, and Singapore. The market shows a low concentration with a Herfindahl-Hirschman Index (HHI) remaining low. The compound annual growth rate (CAGR) for pancrelipase imports to Hong Kong from 2020 to 2024 was an impressive 11.32%, indicating a steady rise in demand. Additionally, the growth rate from 2023 to 2024 stood at 3.29%, suggesting a sustained upward trajectory in the importation of this essential digestive enzyme medication.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Pancrelipase Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Pancrelipase Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Pancrelipase Market - Industry Life Cycle |
3.4 Hong Kong Pancrelipase Market - Porter's Five Forces |
3.5 Hong Kong Pancrelipase Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.6 Hong Kong Pancrelipase Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Hong Kong Pancrelipase Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Hong Kong Pancrelipase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pancreatic disorders in Hong Kong |
4.2.2 Growing awareness about the benefits of pancrelipase in managing pancreatic insufficiency |
4.2.3 Rising adoption of enzyme replacement therapy in the region |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of pancrelipase products |
4.3.2 High cost associated with pancreatic enzyme replacement therapy |
4.3.3 Limited reimbursement options for pancrelipase medications in Hong Kong |
5 Hong Kong Pancrelipase Market Trends |
6 Hong Kong Pancrelipase Market, By Types |
6.1 Hong Kong Pancrelipase Market, By Age |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Pancrelipase Market Revenues & Volume, By Age, 2021- 2031F |
6.1.3 Hong Kong Pancrelipase Market Revenues & Volume, By Children, 2021- 2031F |
6.1.4 Hong Kong Pancrelipase Market Revenues & Volume, By Adults and Geriatrics, 2021- 2031F |
6.2 Hong Kong Pancrelipase Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Pancrelipase Market Revenues & Volume, By Chronic Pancreatitis, 2021- 2031F |
6.2.3 Hong Kong Pancrelipase Market Revenues & Volume, By Cystic Fibrosis, 2021- 2031F |
6.2.4 Hong Kong Pancrelipase Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Hong Kong Pancrelipase Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Pancrelipase Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.3 Hong Kong Pancrelipase Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.4 Hong Kong Pancrelipase Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
7 Hong Kong Pancrelipase Market Import-Export Trade Statistics |
7.1 Hong Kong Pancrelipase Market Export to Major Countries |
7.2 Hong Kong Pancrelipase Market Imports from Major Countries |
8 Hong Kong Pancrelipase Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed pancrelipase treatment |
8.2 Number of healthcare professionals trained in managing pancreatic disorders with pancrelipase therapy |
8.3 Rate of adoption of newer and more effective pancrelipase formulations |
9 Hong Kong Pancrelipase Market - Opportunity Assessment |
9.1 Hong Kong Pancrelipase Market Opportunity Assessment, By Age, 2021 & 2031F |
9.2 Hong Kong Pancrelipase Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Hong Kong Pancrelipase Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Hong Kong Pancrelipase Market - Competitive Landscape |
10.1 Hong Kong Pancrelipase Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Pancrelipase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |